Ameriprise’s SCYNEXIS SCYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,805
Closed -$54K 4038
2022
Q3
$54K Sell
2,805
-588
-17% -$11.5K ﹤0.01% 3891
2022
Q2
$50K Sell
3,393
-75
-2% -$1.44K ﹤0.01% 3829
2022
Q1
$108K Sell
3,468
-250
-7% -$9.56K ﹤0.01% 3843
2021
Q4
$181K Sell
3,718
-6,664
-64% -$328K ﹤0.01% 3804
2021
Q3
$440K Buy
10,382
+3,244
+45% +$170K ﹤0.01% 3448
2021
Q2
$420K Buy
7,138
+3,575
+100% +$226K ﹤0.01% 3523
2021
Q1
$226K Buy
+3,563
New +$234K ﹤0.01% 3679
2017
Q1
Sell
-128
Closed -$33K 3669
2016
Q4
$33K Buy
+128
New +$37.5K ﹤0.01% 3817

Other funds holding SCYX

Ameriprise's SCYX Position: Q4 2022 in Review

Ameriprise sold out of SCYNEXIS (SCYX) in Q4 2022, closing a stake of 2,805 shares — an estimated $54K sold.

Ameriprise first reported a position in SCYX in Q4 2016 and held it in 8 quarters. The position peaked at $440K in Q3 2021. 41 funds tracked by Wall St. Rank hold SCYX as of Q4 2022.

  • Ameriprise reported no remaining SCYNEXIS position as of Q4 2022 after selling out during the quarter.
  • Ameriprise sold 2,805 SCYNEXIS shares in Q4 2022, an estimated $54K.
  • Ameriprise first reported a position in SCYNEXIS in Q4 2016 and held it in 8 quarters.
  • Ameriprise's SCYNEXIS position peaked at $440K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held SCYNEXIS as of Q4 2022.

Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.